As;L'infection rubéolique àl'aube de l'an 2000

Virologie

Volumn 3, Issue 6, 1999, Pages 473-482

  Grangeot Keros, L ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Prenatal diagnosis; Rubella; Serology; Vaccines

Indexed keywords

IMMUNOGLOBULIN M; RUBELLA ANTIBODY; RUBELLA VACCINE;

ANTIBODY DETECTION; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; IMMUNIZATION; INCIDENCE; REVIEW; RUBELLA; VIRUS GENOME;

EID: 0033386155     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Oreinstein WA, Bart KJ, Hinman AR, et al. The opportunity and obligation to eliminate rubella from the United States. JAMA 1984 ; 251 : 1988-94.
2. Jacob S, Rebière I. Epidemiologie de la rubéole chez la femme enceinte et chez le nouveau-né, France, 1976-1995. Réseau national de santé publique, Saint-Maurice, France, décembre 1997 : 97 pages.
3. Che D, Rebiere I. Les infections rubéoleuses chez la femme enceinte et le nouveau-né en France en 1997. Réseau Renarub. BEA. n° 271-5.
4. Rey JL, Delolme H, Gillois P, et al. Couverture vaccinale des jeunes hommes àl'arrivée au service national (avril 1994). BEH 1995 ; 30 : 133-5.
5. Direction centrale du Service de santé des armées. Surveillance épidémiologique hebdomadaire (SEH), années 1996-1998.
6. Tookey PA, Peckham CS. Surveillance of congenital rubella in Great Britain, 1971-1996. BrMedJ 1999 ; 318 :769-70.
7. Adams MS, Croft AMJ, Winfield DA, Richards PR. An outbreak of rubella in British troops in Bosnia. Epidemiol Infect 1997 ; 118 : 253-7.
8. Petrola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994 ; 331 : 1398-402.
9. Ukkonen P. Rubella immunity and morbidity : impact of different vaccination programs in Finland 1979-1992. Scand J Infect Dis 1996 ; 28:31-5.
10. Bottiger M, Forsgren M. Twenty year's experience of rubella vaccination in Sweden : 10 years of selective vaccination (of 12 year-old girls and women post-partum) and 13 years of a general two dose vaccination. Vaccine 1997 ; 15 : 1538-44.
11. Watson JC, HadlerSC, DykewiczCA, ReefS, Phillips L. Measles, mumps and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps : recommandations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998 ; 47 (RR-8) : 1-57.
12. Condon RJ, Bower C. Rubella vaccination and congenital rubella syndrome in Western Australia. MedJAust 1993 ; 158 : 379-82.
13. Cheffins T, Chan A, Keane RJ, Haan EA, Hall R. The impact of rubella immunization on the incidence of rubella, congenital rubella syndrome and rubella related terminations of pregnancy in South Australia. Br J Obstet Gynecol 1998 ; 105 : 998-1004.
14. Cults FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1 : burden of disease from CRS. WHO Bull 1997 ; 75 : 55-68.
15. Frey TK, Abernathy ES, Bosma TJ, et al. Molecular analysis of rubella virus epidemiology across three continents. North America, Europe and Asia, 1961-1997. J Infect Dis 1998; 178:642-50.
16. Plotkin SA. Rubella vaccine. In : Plotkin SA, Mortimer EA, eds. Vaccine, 2nd edition-London, W.B. Saunders, 1994.
17. Robinson K, Mostratos A, Grencis RK. Generation of rubella virusneutralising antibodies by vaccination with synthetic peptides. FEMS ImwwIMcdMicrobiol 1995 ; 10 : 191-8.
18. Qiu Z, Ou D, Wu H, Hobman TC, Gillam S. Expression and characterization of virus like particles containins rubella virus structural proteins. J \1rol 1994 ; 68 : 4086-91.
19. Pougatcheva SO, Abernathy ES, Vzorov AN, Compans RW, Frey TK. Development of a rubella virus DNA vaccine. Vaccine 1999 ; 17:2104-12.
20. O'Shea S, Woodward S, Best JM, Banatvala JE, Holzel H, Dudgeon JA. Rubella vaccination : persistance of antibodies for IQ-21 years. Lancet 1988 ; ii : 909.
21. Howson CP, Finebcrg HV. The ricochet of magic bullet : summary of the Institute of Medicine Report, «Adverse effects of pertussis and rubella vaccines ». Pediatrics 1992 ; 89 : 318-24.
22. Slater PE, Ben-Zvi T, Fogel A, Ehrenfeld M, Ever-Hadani S. Absence of an association between rubella vaccination and arthritis in underimmune post-partum women. Vaccine 1995 ; 13 : 1529-32.
23. Ray P, Black S, Shinefield H, et al. Risk of chronic arthropathy among women after rubella vaccination. JAMA 1997 ; 278 ; 551-6.
24. Frey T. Report of an international meeting on rubella vaccines and vaccination, 9 August 1993, Glasgow, United Kingdom. J Infect Dis 1994 ; 170 : 507-9.
25. Cusi MG, Bianchi S, Santini L, et al. Peripheral neuropathy associated with anti-myelin basic protein antibodies in a woman vaccinated with rubella virus vaccine. J Neurovirol 1999 ; 5 : 209-14.
26. Centers for Disease Control. Rubella vaccination during pregnancy. United States, 1971-1988. MMWR 1989 ; 36 :457-61.
27. Robertson SE, Cults FT, Samuel R, Diaz-Ortega JL. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2 : vaccination against rubella. WHO Bull 1997 ; 75 : 69-80.
28. Grangeot-Keros L. Le sérodiagnostic de la rubéole. Technique et Biologie 1-96 ; 3 : 65-71.
29. Mitchell LA, Zhang T, Ho M, et al. Characterization of rubella virus specific antibody responses by using a new synthetic peptidebased enzyme linked immunosorbent assay. J Clin Microbiol 1992 ; 30: 1841-7.
30. Pustowoit B, Grangeot-Keros L, Hobman TC, Hofmann J. Evaluation of recombinant rubella like particles in a commercial immunoassay for the detection of anti rubella IgG. Clin Diagn Virol 1996 ; 5 : 13-20.
31. O'Shea S, Best JM, Banatvala JE. Viremia, virus excretion and antibody responses after challenge in volunteers with low level of antibody to rubella virus. J Infect Dis 1983 ; 148 : 639-47.
32. Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Patliol 1996 ; 106: 170-4.
33. Thomas HU, Morgan-Capner P, Enders G, O'Shea S, Caldicott D, Best JM. Persistence of specific IgM and low avidity specific IgG I following primary rubella. J Viral Meth 1992 ; 39 : 149-55.
34. 3-1. Grangeot-Keros L, Pillot J, Daffos F, Forestier F. Prenatal diagnosis and postnatal production of IgM and IgA antibodies to rubella virus studied by antibody capture immunoassay. J Infect Dis 1988 ; 158 : 138-43.
35. Enders G, Jonatha W. Prenatal diagnosis of intrauterine rubella. Infection 1987 ; 15 : 162-4.
36. Tanemura M, Suzumori K, Yagami Y, Katow S. Diagnosis of fetal rubella infection with reverse transcription and nested polymerase chain reaction : a study of 34 cases diagnosed in fetuses. Am J Obstet Gynecol 1996; 174:578-82.
37. Revello MG, Baldanti F, Sarasini A, Zavattoni M, Torsellini M, Gerna G. Prenatal diagnosis of rubella virus infection and semiquantitation of viral RNA in clinical samples by reverse transcription - PCR. J Clin Microbiol 1997 ; 35 :708-13.